Authors:
Fogarty, CM
Greenberg, RN
Dunbar, L
Player, R
Marrie, TJ
Kojak, CM
Morgan, N
Williams, RR
Citation: Cm. Fogarty et al., Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: Integrated results from four open-label, multicenter, phase III clinical trials, CLIN THER, 23(3), 2001, pp. 425-439
Authors:
Surawicz, CM
McFarland, LV
Greenberg, RN
Rubin, M
Fekety, R
Mulligan, ME
Garcia, RJ
Brandmarker, S
Bowen, K
Borjal, D
Elmer, GW
Citation: Cm. Surawicz et al., The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii, CLIN INF D, 31(4), 2000, pp. 1012-1017
Authors:
Cagnoni, PJ
Walsh, TJ
Prendergast, MM
Bodensteiner, D
Hiemenz, S
Greenberg, RN
Arndt, CAS
Schuster, M
Seibel, N
Yeldandi, V
Tong, KB
Citation: Pj. Cagnoni et al., Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients, J CL ONCOL, 18(12), 2000, pp. 2476-2483
Authors:
Carrithers, SL
Eber, SL
Forte, LR
Greenberg, RN
Citation: Sl. Carrithers et al., Increased urinary excretion of uroguanylin in patients with congestive heart failure, AM J P-HEAR, 278(2), 2000, pp. H538-H547
Authors:
Plouffe, J
Schwartz, DB
Kolokathis, A
Sherman, BW
Arnow, PM
Gezon, JA
Suh, B
Anzuetto, A
Greenberg, RN
Niederman, M
Paladino, JA
Ramirez, JA
Inverso, J
Knirsch, CA
Citation: J. Plouffe et al., Clinical efficacy of intravenous followed by oral azithromycin monotherapyin hospitalized patients with community-acquired pneumonia, ANTIM AG CH, 44(7), 2000, pp. 1796-1802
Authors:
Greenberg, RN
Newman, MT
Shariaty, S
Pectol, RW
Citation: Rn. Greenberg et al., Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis, ANTIM AG CH, 44(1), 2000, pp. 164-166
Citation: Cn. Mayhew et al., In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity, STEM CELLS, 17(6), 1999, pp. 345-356
Citation: Rn. Greenberg et E. Martin, Pneumococcal pneumonia in adults treated at University of Kentucky MedicalCenter, 1995-1998: Implications of pathogen resistance, CLIN INF D, 28(5), 1999, pp. 1160-1162
Authors:
Elmer, GW
McFarland, LV
Surawicz, CM
Danko, L
Greenberg, RN
Citation: Gw. Elmer et al., Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients, ALIM PHARM, 13(12), 1999, pp. 1663-1668
Authors:
McFarland, LV
Surawicz, CM
Greenberg, RN
Bowen, KE
Melcher, SA
Mulligan, ME
Citation: Lv. Mcfarland et al., Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections, AM J INFECT, 27(3), 1999, pp. 301-303
Authors:
Walsh, TJ
Finberg, RW
Arndt, C
Hiemenz, J
Schwartz, C
Bodensteiner, D
Pappas, P
Seibel, N
Greenberg, RN
Dummer, S
Schuster, M
Holcenberg, JS
Citation: Tj. Walsh et al., Liposomal amphotericin B for empirical therapy in patients with persistentfever and neutropenia, N ENG J MED, 340(10), 1999, pp. 764-771